Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The ‘green technology’ allows the extraction of cosmetically active compounds from plants using root exudation without harming the plants involved. More
Disclosed herein are a pharmaceutical formulation with high stability and dissolution, and a method for preparing the pharmaceutical formulation, More
The plant milking technology is capable of producing high value active pharmaceutical compounds More
Rheumatoid arthritis More
An expression array diagnostic tool to predict survival in cancer patients, as well as, composition and methods to induce the predictive gene expression profile More
Derivatives of Butyric Acid and Uses Thereof - treatment of autoimmune More
when used in combination with other drugs these UGT inhibitors act to significantly enhance efficacy antiviral therapeutics that require UGT's for their systemic clearance. More
tissue for in vitro analysis of drug metabolic conversions More
A series of substituted 3,6-diphenyl-7H-[1,2,4] triazolo[3,4-b] [1,3,4] thiadiazines that act as inhibitors of PDE4 More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 36 pages - $500
Dec 2008 - 35 pages - $200
May 2011 - 25 pages - $250
Dec 2010 - 15 pages - $500
Dec 2010 - 16 pages - $500
Nov 2010 - 68 pages - $600
Nov 2010 - 56 pages - $600
Nov 2010 - 92 pages - $600
Nov 2010 - 179 pages - $600
Nov 2010 - 60 pages - $600
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us